Del Trade

Delhi, India Founded: 2010 • Age: 16 yrs
Serves as a distributor of a wide range of pharmaceutical drugs.
Annual revenue $59.2M Latest available
Total funding - Funding intelligence
Employees 66 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 7 Brand Intelligence

About Del Trade

Del Trade is a company based in Delhi (India) founded in 2010 by Nitin Aggarwal. It operates as a B2B. The company has 66 employees as of March 31, 2024. Del Trade operates in a competitive market with competitors including Globofarm International, HUFORT HEALTHCARE, Nishchem, Pals Pharma and J B Khokhani, among others.

  • Headquarter Delhi, India
  • Employees 66 as on 31 Mar, 2024
  • Founders Nitin Aggarwal
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Del Trade International Private Limited
  • Date of Incorporation 23 Aug, 2010
  • Jurisdiction Delhi, Delhi, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $59.24 M (USD)
    21.6
    as on Mar 31, 2024
  • Net Profit
    $900.48 K (USD)
    91.06
    as on Mar 31, 2024
  • EBITDA
    $1.5 M (USD)
    35.75
    as on Mar 31, 2024
  • Latest Funding Round
  • Investors
  • Employee Count
    66

    as on Mar 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Del Trade

Investments & Acquisitions by Del Trade

Investments

Financial Statements - Del Trade

Del Trade Comparisons

+
Add Comparison
Available on Premium

Competitors of Del Trade

Del Trade operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Globofarm International, HUFORT HEALTHCARE, Nishchem, Pals Pharma and J B Khokhani, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Manufactures and supplies pharmaceutical ingredients and wellness products worldwide.
domain founded_year HQ Location
Distributes pharmaceutical raw materials through import, stock, and sales services.
domain founded_year HQ Location
Manufactures and distributes pharmaceutical APIs and formulations globally with import and export services.
domain founded_year HQ Location
Sourcing and marketing of pharmaceutical ingredients and products worldwide.
domain founded_year HQ Location
Distributes active pharmaceutical ingredients to industry clients.

Latest news on Del Trade

Frequently Asked Questions about Del Trade

Del Trade was founded in 2010.

Del Trade is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

As of Mar 31, 2024, the latest employee count at Del Trade is 66.

Annual revenue of Del Trade is $59.24M as on Mar 31, 2024.

Del Trade operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, distribution, and drug supply. Serves as a distributor of a wide range of pharmaceutical drugs. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.

Del Trade's top competitors include Globofarm International, HUFORT HEALTHCARE and Nishchem.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available